Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer

NCT06736054 is registered in ClinicalTrials.gov with Hoag Memorial Hospital Presbyterian as lead sponsor.

NCT NCT06736054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06736054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
Lead sponsor
Hoag Memorial Hospital Presbyterian
Phase
Phase 1
Overall status
Recruiting
Start date
October 14, 2024
Completion date
March 31, 2025
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma